The Construction of Market Entry Model to Biotech Pharmaceutical Industry in China Market
碩士 === 國立臺灣科技大學 === 工業管理系 === 99 === China as the largest emerging market in the world becomes a potential place and attracts Multi-National Corporations (MNCs) to invest. However, MNCs were faced with unprecedented challenges and difficulties due to the complication and dynamic of China market. Und...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2010
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/76456310345974084161 |
| Summary: | 碩士 === 國立臺灣科技大學 === 工業管理系 === 99 === China as the largest emerging market in the world becomes a potential place and attracts Multi-National Corporations (MNCs) to invest. However, MNCs were faced with unprecedented challenges and difficulties due to the complication and dynamic of China market. Understanding the characteristics of biotech pharmaceutical industry in China and how to enter China market becomes a fundamental issue. This study investigates biotech pharmaceutical industry and proposes a market entry model to China market. Besides, this study also discusses the core competencies when MNCs enter biotech pharmaceutical industry in China for extending their business successfully and surviving in market. Through analyzing the transcriptions form in-depth interview with experts who represented successful Multi-National Corporations in China market, this study classifies the critical factors for market entry model of biotech pharmaceutical industry. This study concludes with 2 results, the market entry model with two stages –“Market Entry Analysis” and “Market Entry Strategy” and the main Core Competencies as the element lead MNCs be successful in China.
|
|---|